These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17541977)

  • 1. X-ray powder diffractometry of intact film coated tablets--an approach to monitor the physical form of the active pharmaceutical ingredient during processing and storage.
    Yamada H; Suryanarayanan R
    J Pharm Sci; 2007 Aug; 96(8):2029-36. PubMed ID: 17541977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
    Cooper VB; Pearce GE; Petts CR
    J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-destructive determination of the coating film thickness by X-ray powder diffractometry and correlation with the dissolution behavior of film-coated tablets.
    Yamada H; Terada K; Suryanarayanan R
    J Pharm Biomed Anal; 2010 Mar; 51(4):952-7. PubMed ID: 19945243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study between conventional pan coater and quasi-continuous small batch coater on the stability of tablets containing acetylsalicylic acid.
    Cahyadi C; Chan LW; Heng PW
    Eur J Pharm Biopharm; 2015 Feb; 90():30-7. PubMed ID: 25448074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculation of the penetration depth of X-rays in intact pharmaceutical film-coated tablets by microdiffractometry.
    Yamada H; Suryanarayanan R
    Pharm Res; 2006 Sep; 23(9):2149-57. PubMed ID: 16906453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies.
    Missaghi S; Young C; Fegely K; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2010 Feb; 36(2):180-9. PubMed ID: 20070183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid conversion of API hydrates to anhydrous forms in aqueous media.
    Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM
    J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical stability of crystal hydrates and their anhydrates in the presence of excipients.
    Salameh AK; Taylor LS
    J Pharm Sci; 2006 Feb; 95(2):446-61. PubMed ID: 16380975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
    Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the aqueous film coating process on the properties and stability of tablets containing a moisture-labile drug.
    Ruotsalainen M; Heinämäki J; Taipale K; Yliruusi J
    Pharm Dev Technol; 2003; 8(4):443-51. PubMed ID: 14601968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of solid-state forms of a pharmaceutical development compound in drug substance and tablets.
    Xie Y; Tao W; Morrison H; Chiu R; Jona J; Fang J; Cauchon N
    Int J Pharm; 2008 Oct; 362(1-2):29-36. PubMed ID: 18588963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in Transitioning Cocrystals from Bench to Bedside: Dissociation in Prototype Drug Product Environment.
    Koranne S; Sahoo A; Krzyzaniak JF; Luthra S; Arora KK; Suryanarayanan R
    Mol Pharm; 2018 Aug; 15(8):3297-3307. PubMed ID: 29947519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the subambient behavior of aqueous mannitol solutions using temperature-controlled Raman microscopy.
    Beattie JR; Barrett LJ; Malone JF; McGarvey JJ; Nieuwenhuyzen M; Kett VL
    Eur J Pharm Biopharm; 2007 Sep; 67(2):569-78. PubMed ID: 17481870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing-induced phase transitions of theophylline--implications on the dissolution of theophylline tablets.
    Tantry JS; Tank J; Suryanarayanan R
    J Pharm Sci; 2007 May; 96(5):1434-44. PubMed ID: 17455350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of polymorphic forms of ranitidine hydrochloride.
    Wu V; Rades T; Saville DJ
    Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.